Selah House Outpatient Eating Disorder Treatment Clinic Opens in Columbus, Ohio
June 02, 2022 10:00 ET
|
Odyssey Behavioral Healthcare
BRENTWOOD, Tenn., June 02, 2022 (GLOBE NEWSWIRE) -- Odyssey Behavioral Healthcare ("Odyssey"), nationally recognized for eating disorder and mental health disorder treatment, is excited to announce...
Cerberus Sentinel completes acquisition of Creatrix, Inc.
June 02, 2022 08:05 ET
|
Cerberus Cyber Sentinel Corporation
Scottsdale, Ariz., June 02, 2022 (GLOBE NEWSWIRE) -- via Investor Wire -- Cerberus Cyber Sentinel Corporation (NASDAQ: CISO), a cybersecurity consulting and managed services firm based in...
Evening Virtual Intensive Outpatient Program (V-IOP) Now Available for North Carolina Residents
May 31, 2022 10:00 ET
|
Odyssey Behavioral Healthcare
BRENTWOOD, Tenn., May 31, 2022 (GLOBE NEWSWIRE) -- Odyssey Behavioral Healthcare ("Odyssey"), nationally recognized for mental health and eating disorder treatment, is excited to announce the launch...
Odyssey Behavioral Healthcare Welcomes Justin Adams as Chief Operating Officer
May 11, 2022 10:00 ET
|
Odyssey Behavioral Healthcare
BRENTWOOD, Tenn., May 11, 2022 (GLOBE NEWSWIRE) -- Odyssey Behavioral Healthcare, a leading national behavioral health treatment network, is pleased to announce that Justin Adams, MBA, has been...
Wesley Mortgage Announces New Leadership In Key Executive Roles
May 09, 2022 11:03 ET
|
Wesley Mortgage
FRANKLIN, TN, May 09, 2022 (GLOBE NEWSWIRE) -- Wesley Mortgage, LLC, the official mortgage provider of the Tennessee Titans, continues to build the company’s regional and national footprint with the...
ARC Federal Co-Chair Manchin, Governors, and Tourism Experts Highlight Value of Investments in Tourism & Culture in Appalachian North Carolina, Kentucky, Tennessee, and West Virginia
May 04, 2022 15:17 ET
|
Appalachian Regional Commission
Washington, DC, May 04, 2022 (GLOBE NEWSWIRE) -- On May 3, the Appalachian Regional Commission (ARC) held the second in a series of five virtual events (titled the Appalachia Envisioned Roadshow) to...
Provectus Biopharmaceuticals Announces Acceptance of PV-10® Immunotherapy Abstract for Metastatic Uveal Melanoma at American Society of Clinical Oncology (ASCO) 2022 Annual Meeting
April 27, 2022 10:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, April 27, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that data from an ongoing clinical trial of investigational cancer immunotherapy PV-10, a formulation of...
Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent Application for Use of PV-10® Immunotherapy in Hematology
April 26, 2022 07:30 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, April 26, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed US patent application 16/688,319,...
Provectus Biopharmaceuticals Seeks Stockholder Approval at 2022 Annual Meeting for Authority to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio
April 19, 2022 16:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, April 19, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that, in conjunction with the filing of the Company’s preliminary 2022 proxy statement (Pre-14A), Provectus’...
Renasant Named a Top Bank by Forbes
April 19, 2022 15:21 ET
|
Renasant Corporation
TUPELO, Miss., April 19, 2022 (GLOBE NEWSWIRE) -- Renasant Corporation (NASDAQ: RNST) today announced that Forbes has named Renasant Bank as one of the best banks in the world in its World's Best...